WHITLEY HOUSE SURGERY — All Prescriptions & Medications — Page 10
Practice Code: F81057 | CHELMSFORD, CM1 3RW
Showing results 451-500 of 607
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 24 | 240 | £66 | +85.9% ▲ | |
| 24 | 730 | £4.3K | +108.6% ▲ | |
| Cimetidine | 23 | 1,344 | £161 | +23.3% ▲ |
| Testosterone undecanoate | 23 | 23 | £2.0K | -9.4% ▼ |
| Azelastine hydrochloride | 23 | 506 | £230 | +105.2% ▲ |
| Simeticone | 22 | 543 | £87 | +301.3% ▲ |
| Safinamide | 22 | 495 | £1.1K | +9.2% ▲ |
| Methotrexate | 22 | 88 | £1.3K | -26.2% ▼ |
| 22 | 395 | £138 | -24.0% ▼ | |
| 22 | 4,080 | £6.5K | +24.8% ▲ | |
| 22 | 1,180 | £5.1K | -1.4% vs avg | |
| Dipyridamole | 21 | 1,800 | £537 | -18.2% ▼ |
| Atomoxetine hydrochloride | 21 | 588 | £1.3K | -37.9% ▼ |
| Clonidine hydrochloride | 21 | 2,464 | £243 | -60.6% ▼ |
| Testosterone | 21 | 4,436 | £1.8K | -72.5% ▼ |
| Triptorelin acetate | 21 | 21 | £1.4K | +46.5% ▲ |
| Ciprofloxacin | 21 | 335 | £128 | +127.8% ▲ |
| Other individually formulated bought in preparations | 21 | 2,682 | £154 | -35.7% ▼ |
| 21 | 2,660 | £2.0K | -36.5% ▼ | |
| 21 | 1,406 | £6.1K | +78.8% ▲ | |
| Codeine phosphate | 20 | 3,800 | £129 | +39.3% ▲ |
| Acamprosate calcium | 20 | 2,100 | £235 | -42.6% ▼ |
| Glimepiride | 20 | 584 | £16 | -78.3% ▼ |
| Propylthiouracil | 20 | 2,160 | £328 | +59.1% ▲ |
| Clindamycin phosphate | 20 | 800 | £207 | +379.4% ▲ |
| Hypromellose | 20 | 530 | £243 | -84.9% ▼ |
| Chlorhexidine gluconate | 20 | 10.0K | £637 | -32.3% ▼ |
| 20 | 56 | £741 | +96.1% ▲ | |
| 20 | 3,900 | £755 | -26.8% ▼ | |
| Mebeverine hydrochloride compound preparations | 19 | 760 | £662 | +68.1% ▲ |
| INR blood testing reagents | 19 | 480 | £1.4K | +152.2% ▲ |
| Bupropion hydrochloride | 19 | 1,140 | £754 | +75.8% ▲ |
| Tetracycline | 19 | 2,148 | £1.5K | +306.3% ▲ |
| Estradiol and estriol with progestogen | 19 | 1,204 | £153 | +380.8% ▲ |
| Amorolfine hydrochloride | 19 | 95 | £112 | -17.7% ▼ |
| Colestyramine | 18 | 1,400 | £303 | -37.5% ▼ |
| Doxepin | 18 | 1,120 | £3.0K | +38.5% ▲ |
| Glipizide | 18 | 504 | £23 | +51.0% ▲ |
| Tibolone | 18 | 980 | £91 | -41.2% ▼ |
| Combined ethinylestradiol 35mcg | 18 | 1,848 | £125 | +44.5% ▲ |
| Calcitriol | 18 | 1,036 | £236 | +15.4% ▲ |
| Etodolac | 18 | 506 | £250 | -35.0% ▼ |
| Azelastine hydrochloride | 18 | 160 | £122 | +51.4% ▲ |
| Dexamethasone sodium metasulphobenzoate | 18 | 144 | £128 | +142.2% ▲ |
| 18 | 500 | £6.4K | +72.2% ▲ | |
| Flupentixol hydrochloride | 17 | 1,836 | £121 | -48.1% ▼ |
| Rimegepant | 17 | 332 | £4.3K | +73.3% ▲ |
| Rasagiline mesilate | 17 | 476 | £396 | -54.2% ▼ |
| Hydroxycarbamide | 17 | 1,100 | £172 | -41.1% ▼ |
| Leuprorelin acetate | 17 | 17 | £3.2K | -63.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.